Risk of Hospital Encounters With Kidney Stones in Autosomal Dominant Polycystic Kidney Disease: A Cohort Study

被引:3
|
作者
Kalatharan, Vinusha [1 ]
Welk, Blayne [1 ,2 ]
Nash, Danielle M. [1 ,2 ]
Dixon, Stephanie N. [1 ,2 ]
Slater, Justin [2 ]
Pei, York [3 ]
Sarma, Sisira [1 ,2 ]
Garg, Amit X. [1 ,2 ,4 ]
机构
[1] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada
[2] ICES, London, ON, Canada
[3] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada
[4] Western Univ, Dept Med, Div Nephrol, London, ON, Canada
基金
加拿大健康研究院;
关键词
administrative data; autosomal dominant polycystic kidney disease; epidemiology; kidney stones; population health research; IDENTIFYING PATIENTS; PROGRESSION; EPIDEMIOLOGY; VALIDITY;
D O I
10.1177/20543581211000227
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: There is a perception that patients with autosomal dominant polycystic kidney disease (ADPKD) are more likely to develop kidney stones than the general population. Objective: To compare the rate of hospital encounter with kidney stones and the rate of stone interventions between patients with and without ADPKD. Design: Retrospective cohort study. Setting: Ontario, Canada. Patients: Patients with and without ADPKD who had a prior hospital encounter between 2002 and 2016. Measurements: Rate of hospital encounter with kidney stones and rate of stone intervention. Methods: We used inverse probability exposure weighting based on propensity scores to balance baseline indicators of health between patients with and without ADPKD. We followed each patient until death, emigration, outcomes, or March 31, 2017. We used a Cox proportional hazards model to compare event rates between the two groups. Results: Patients with ADPKD were at higher risk of hospital encounter with stones compared with patients without ADPKD (81 patients of 2094 with ADPKD [3.8%] vs 60 patients of 1902 without ADPKD [3.2%]; 8.9 vs 5.1 events per 1000 person-years; hazard ratio 1.6 [95% CI, 1.3-2.1]). ADPKD was not associated with a higher risk of stone intervention (49 of 2094 [2.3%] vs 47 of 1902 [2.4%]; 5.3 vs 3.9 events per 1000 person-years; hazard ratio 1.2 [95% CI = 0.9-1.3]). Limitations: We did not have information on kidney stone events outside of the hospital. There is a possibility of residual confounding. Conclusion: ADPKD was a significant risk factor for hospital encounters with kidney stones.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease
    Schrier, RW
    McFann, KK
    Johnson, AM
    KIDNEY INTERNATIONAL, 2003, 63 (02) : 678 - 685
  • [22] Mortality risk in patients with autosomal dominant polycystic kidney disease
    Mladsi, Deirdre
    Zhou, Xiaolei
    Mader, Gregory
    Sanon, Myrlene
    Wang, Jinyi
    Barnett, Christine
    Willey, Cynthia
    Seliger, Stephen
    BMC NEPHROLOGY, 2024, 25 (01)
  • [23] Autosomal dominant polycystic kidney disease: Cardiovascular risk factor
    Martinez, Miguel Angel Gonzalez
    Garcia, Elena Hernandez
    Garcia, Ana Isabel Morales
    MEDICINA CLINICA, 2023, 161 (06): : 271 - 272
  • [24] Mortality risk in patients with autosomal dominant polycystic kidney disease
    Deirdre Mladsi
    Xiaolei Zhou
    Gregory Mader
    Myrlene Sanon
    Jinyi Wang
    Christine Barnett
    Cynthia Willey
    Stephen Seliger
    BMC Nephrology, 25
  • [25] Renal stones in patients with autosomal dominant polycystic kidney disease, a treatment challenge?
    Koorevaar, Iris W.
    Gansevoort, Ron T.
    Leliveld, Anna M.
    Casteleijn, Niek F.
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2020, 24 (11) : 1088 - 1089
  • [26] Renal stones in patients with autosomal dominant polycystic kidney disease, a treatment challenge?
    Iris W. Koorevaar
    Ron T. Gansevoort
    Anna M. Leliveld
    Niek F. Casteleijn
    Clinical and Experimental Nephrology, 2020, 24 : 1088 - 1089
  • [27] Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease
    Serra, Andreas L.
    Poster, Diane
    Kistler, Andreas D.
    Krauer, Fabienne
    Raina, Shagun
    Young, James
    Rentsch, Katharina M.
    Spanaus, Katharina S.
    Senn, Oliver
    Kristanto, Paulus
    Scheffel, Hans
    Weishaupt, Dominik
    Wuethrich, Rudolf P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09): : 820 - 829
  • [28] Kidney and liver cysts in autosomal dominant polycystic kidney disease
    Bichet, Daniel G.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (11) : 3472 - 3473
  • [29] Kidney volume and function in autosomal dominant polycystic kidney disease
    Eiji Higashihara
    Kikuo Nutahara
    Takatsugu Okegawa
    Toshihide Shishido
    Mitsuhiro Tanbo
    Kuninori Kobayasi
    Toshiaki Nitadori
    Clinical and Experimental Nephrology, 2014, 18 : 157 - 165
  • [30] Kidney volume and function in autosomal dominant polycystic kidney disease
    Higashihara, Eiji
    Nutahara, Kikuo
    Okegawa, Takatsugu
    Shishido, Toshihide
    Tanbo, Mitsuhiro
    Kobayasi, Kuninori
    Nitadori, Toshiaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (01) : 157 - 165